IBDEI2L7 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43914,1,4,0)
 ;;=4^I35.8
 ;;^UTILITY(U,$J,358.3,43914,2)
 ;;=^5007177
 ;;^UTILITY(U,$J,358.3,43915,0)
 ;;=I35.9^^170^2108^12
 ;;^UTILITY(U,$J,358.3,43915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43915,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorders,Unspec
 ;;^UTILITY(U,$J,358.3,43915,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,43915,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,43916,0)
 ;;=I48.91^^170^2108^5
 ;;^UTILITY(U,$J,358.3,43916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43916,1,3,0)
 ;;=3^Atrial Fibrillation,Unspec
 ;;^UTILITY(U,$J,358.3,43916,1,4,0)
 ;;=4^I48.91
 ;;^UTILITY(U,$J,358.3,43916,2)
 ;;=^5007229
 ;;^UTILITY(U,$J,358.3,43917,0)
 ;;=I49.9^^170^2108^6
 ;;^UTILITY(U,$J,358.3,43917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43917,1,3,0)
 ;;=3^Cardiac Arrhythmia,Unspec
 ;;^UTILITY(U,$J,358.3,43917,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,43917,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,43918,0)
 ;;=I50.9^^170^2108^8
 ;;^UTILITY(U,$J,358.3,43918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43918,1,3,0)
 ;;=3^Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,43918,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,43918,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,43919,0)
 ;;=I73.9^^170^2108^16
 ;;^UTILITY(U,$J,358.3,43919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43919,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,43919,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,43919,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,43920,0)
 ;;=I87.2^^170^2108^18
 ;;^UTILITY(U,$J,358.3,43920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43920,1,3,0)
 ;;=3^Venous Insufficiency,Chronic,Peripheral
 ;;^UTILITY(U,$J,358.3,43920,1,4,0)
 ;;=4^I87.2
 ;;^UTILITY(U,$J,358.3,43920,2)
 ;;=^5008047
 ;;^UTILITY(U,$J,358.3,43921,0)
 ;;=R07.9^^170^2108^7
 ;;^UTILITY(U,$J,358.3,43921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43921,1,3,0)
 ;;=3^Chest Pain,Unspec
 ;;^UTILITY(U,$J,358.3,43921,1,4,0)
 ;;=4^R07.9
 ;;^UTILITY(U,$J,358.3,43921,2)
 ;;=^5019201
 ;;^UTILITY(U,$J,358.3,43922,0)
 ;;=E03.9^^170^2109^18
 ;;^UTILITY(U,$J,358.3,43922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43922,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,43922,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,43922,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,43923,0)
 ;;=E11.9^^170^2109^10
 ;;^UTILITY(U,$J,358.3,43923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43923,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,43923,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,43923,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,43924,0)
 ;;=E10.9^^170^2109^6
 ;;^UTILITY(U,$J,358.3,43924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43924,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,43924,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,43924,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,43925,0)
 ;;=E11.65^^170^2109^8
 ;;^UTILITY(U,$J,358.3,43925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43925,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,43925,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,43925,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,43926,0)
 ;;=E10.65^^170^2109^4
 ;;^UTILITY(U,$J,358.3,43926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43926,1,3,0)
 ;;=3^Diabetes Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,43926,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,43926,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,43927,0)
 ;;=E11.8^^170^2109^7
 ;;^UTILITY(U,$J,358.3,43927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43927,1,3,0)
 ;;=3^Diabetes Type 2 w/ Complications,Unspec
 ;;^UTILITY(U,$J,358.3,43927,1,4,0)
 ;;=4^E11.8
